Royal Bank of Canada’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,344
| Closed | -$18K | – | 7524 |
|
|
2025
Q4 | $18K | Sell |
2,344
-94,205
| -98% | -$1.08M | ﹤0.01% | 6116 |
|
|
2025
Q3 | $1.16M | Sell |
96,549
-3,350
| -3% | -$35.2K | ﹤0.01% | 3864 |
|
|
2025
Q2 | $1.01M | Buy |
99,899
+95,065
| +1,967% | +$638K | ﹤0.01% | 3883 |
|
|
2025
Q1 | $27K | Sell |
4,834
-2,913
| -38% | -$25.5K | ﹤0.01% | 5814 |
|
|
2024
Q4 | $63K | Buy |
7,747
+823
| +12% | +$7.55K | ﹤0.01% | 5575 |
|
|
2024
Q3 | $71K | Buy |
6,924
+633
| +10% | +$6.26K | ﹤0.01% | 5537 |
|
|
2024
Q2 | $45K | Buy |
6,291
+4,908
| +355% | +$43.9K | ﹤0.01% | 5705 |
|
|
2024
Q1 | $19K | Sell |
1,383
-10,143
| -88% | -$120K | ﹤0.01% | 5944 |
|
|
2023
Q4 | $106K | Buy |
11,526
+4,972
| +76% | +$36K | ﹤0.01% | 5593 |
|
|
2023
Q3 | $40K | Buy |
6,554
+2,483
| +61% | +$20.3K | ﹤0.01% | 5894 |
|
|
2023
Q2 | $32K | Buy |
4,071
+4,065
| +67,750% | +$23.1K | ﹤0.01% | 5980 |
|
|
2023
Q1 | $0 | Sell |
6
-185
| -97% | -$967 | ﹤0.01% | 7354 |
|
|
2022
Q4 | $1K | Sell |
191
-896
| -82% | -$3.02K | ﹤0.01% | 7059 |
|
|
2022
Q3 | $3K | Buy |
1,087
+570
| +110% | +$2.28K | ﹤0.01% | 6911 |
|
|
2022
Q2 | $2K | Sell |
517
-3,425
| -87% | -$13.7K | ﹤0.01% | 6981 |
|
|
2022
Q1 | $21K | Sell |
3,942
-2,157
| -35% | -$19.4K | ﹤0.01% | 6581 |
|
|
2021
Q4 | $90K | Buy |
6,099
+2,729
| +81% | +$42.6K | ﹤0.01% | 6018 |
|
|
2021
Q3 | $70K | Buy |
3,370
+1,350
| +67% | +$27.4K | ﹤0.01% | 5956 |
|
|
2021
Q2 | $36K | Buy |
2,020
+29
| +1% | +$635 | ﹤0.01% | 6242 |
|
|
2021
Q1 | $49K | Buy |
1,991
+1,482
| +291% | +$46.8K | ﹤0.01% | 5902 |
|
|
2020
Q4 | $17K | Buy |
509
+488
| +2,324% | +$14K | ﹤0.01% | 6139 |
|
|
2020
Q3 | $1K | Buy |
+21
| New | +$500 | ﹤0.01% | 6462 |
|
Other funds holding ORIC
NI
EC
SOCM
P
VA
NMC